CAMO 2018 ANNUAL SCIENTIFIC MEETING RÉUNION ANNUELLE SCIENTIFIQUE 2018 de l ACOM

Transcription

1 CAMO 2018 ANNUAL SCIENTIFIC MEETING RÉUNION ANNUELLE SCIENTIFIQUE 2018 de l ACOM FINAL PROGRAM PROGRAMME FINAL Thursday, April 26, 2018 Jeudi le 26 avril 2018 Chelsea Hotel Toronto, Ontario Co-chair: Dr. David Dawe Co-chair: Dr. Jean-Pierre Ayoub

2 2018 CAMO Annual Scientific Meeting Réunion annuelle scientifique de l ACOM Chelsea Hotel Toronto, ON Wednesday, April 25 / mercredi le 25 avril 2018 Room: Rossetti 17h45 20h45 Oncology Education Evening Talk INTEGRATION OF ONCOLOGY BIOSIMILARS IN CLINICAL CARE Objectives 1. Review fundamental biology of biosimilars. 2. Discuss policy issues governing the approval and clinical use of biosimilars. 3. Describe the current availability of biosimilars and their integration into clinical practice. 4. Investigate the challenges regarding biosimilars, their integration into clinical practice and patient treatment. UNDERSTANDING THE SCIENCE OF BIOSIMILARS: HOW ARE THEY DIFFERENT FROM EMERGING DRUGS? WHAT ARE THEY AND HOW ARE THEY CREATED? Dr. Sandy Sehdev CLINICAL DATA ON BIOSIMILARS: BREAST CANCER Dr. Sunil Verma CLINICAL DATA ON BIOSIMILARS: COLORECTAL CANCER Dr. Scott Berry Thursday, April 26 / jeudi le 26 avril 2018 Room: Mountbatten AB 07h00 17h00 CAMO Registration Desk Opens / Ouverture du bureau d inscription de l ACOM 07h00 08h15 Breakfast Symposium/Déjeuner Conférence 08h15 08h30 Coffee Break/Pause-café 08h30 10h30 CAMO Oral Presentations/Présentations de résumés Objectives 1. Describe recent research findings in the field of Medical Oncology. 2. Describe interesting cases in the field of Medical Oncology. PLASMA MIR371 FOR THE DETECTION OF VIABLE GERM CELL TUMOR Dr. Lucia Nappi DETERMINING BIOMARKERS OF RESPONSE TO DOCETAXEL FOR PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) USING CIRCULATING CELL-FREE TUMOR DNA (CTDNA) Dr. Daniel Khalaf OUTCOMES IN METASTATIC CASTRATION RESISTANT PROSTATE CANCER (MCRPC) PATIENTS WITH SOMATIC AND GERMLINE HOMOLOGOUS RECOMBINATION REPAIR (HRR) GENE MUTATIONS Dr. Steven Yip POPULATION BASED ANALYSIS OF MALE PATIENTS WITH BREAST CANCER IN ALBERTA Dr. Osama Ahmed POTENTIAL LIFE-YEARS LOST: THE IMPACT OF THE CANCER DRUG REGULATORY PROCESS IN CANADA Dr. Joanna Gotfrit OUTCOMES AND CHARACTERISTICS OF PATIENTS RECEIVING SECOND-LINE THERAPY FOR ADVANCED PANCREATIC CANCER Dr. Erica Tsang WHOLE GENOME SEQUENCING IN METASTATIC BREAST CANCER LESSONS LEARNED FROM THE BC CANCER PERSONALIZED ONCOGENOMICS PROGRAM Dr. Nathalie Levasseur SCREENING FOR NEW PRIMARY CANCERS IN PATIENTS WITH METASTATIC BREAST CANCER: A PROVINCIAL ANALYSIS OF THE CHOOSING WISELY CANADA RECOMMENDATIONS Dr. Megan Tesch 10h30 11h00 Poster viewing and networking break/présentations d affiches et réseautage

3 2018 CAMO Annual Scientific Meeting Réunion annuelle scientifique de l ACOM Chelsea Hotel Toronto, ON Thursday, April 26 / jeudi le 26 avril 2018 Room: Mountbatten AB 11h00 12h00 CAMO Keynote Speaker MEDICAL CANNABIS-WEEDING OUT STIGMA AND CULTIVATING EVIDENCE Speaker: Dr. Vincent Maida, MD, MSc, BSc, CCFP (PC), FCFP, ABHPM Objectives (40 minute presentation, followed by 15 minute Q&A) 1. Understand the endocannabinoid system and realize the potential for cannabinoid therapies for pain & symptom management in oncologic supportive care. 2. Identify the range of cannabinoid therapies and their multiple routes of administration. 3. Distinguish Recreational Marijuana from Medical Cannabis, and learn how to authorize legalized Medical Cannabis under the revised Health Canada regulations. 12h15 13h30 CAMO Annual General Meeting & Lunch/ Réunion d affaires annuelle de l ACOM & dîner (members only/membres seulement) (Room: Wren 3 rd Floor) 12h15 13h30 Lunch for Delegates/Dîner des délégués (Room: Mountbatten AB) 13h45 14h00 CAMO/RX&D Fellowship Presentations Best Resident Abstracts Dr. Bindi Dhesy-Thind Chair, Fellowship Commitee Dr. David Dawe & Dr. Jean-Pierre Ayoub Co-chairs, Annual Scientific Meeting Committee 14h00 16h55 CAMO Symposium BEYOND SYSTEMIC THERAPY: OTHER WAYS FOR MEDICAL ONCOLOGISTS TO HELP PATIENTS 14h05 14h40 SMOKING CESSATION: ALWAYS A PREVENTIVE PRIORITY Speaker: Dr. Andrew Pipe, CM, MD, LLD(Hon), DSc(Hon), Professor, Faculty of Medicine, University of Ottawa Objectives (25 minute presentation, followed by 10 minute Q&A) 1. Explain the importance of addressing smoking cessation in the oncology setting. 2. Summarize the use of pharmacotherapies for smoking cessation. 3. Demonstrate an appropriate intervention identifying the importance of cessation to an oncology patient. 14h40 15h15 PHYSICAL ACTIVITY DURING CANCER TREATMENT: REVIEW OF EVIDENCE AND RECOMMENDATIONS Speaker: Dr. Christine Friedenreich, Scientific Leader, Cancer Epidemiology and Prevention Research, Alberta Health Services and Division Head, Preventive Oncology, Department of Oncology, Cumming School of Medicine, University of Calgary Objectives (25 minute presentation, followed by 10 minute Q&A) 1. To know the strength of the evidence regarding the role of physical activity as an adjuvant therapy for cancer patients during treatment. 2. To list the recommended type, levels and amounts of physical activity for cancer patients. 3. To know the resources available for cancer patients to educate and support them to incorporate physical activity in their treatment plans.

4 2018 CAMO Annual Scientific Meeting Réunion annuelle scientifique de l ACOM Chelsea Hotel Toronto, ON Thursday, April 26 / jeudi le 26 avril 2018 Room: Mountbatten AB 15h15 15h45 Poster viewing and networking break/présentations d affiches et réseautage 15h45 16h20 PATIENT REPORTED OUTCOMES IN ROUTINE CLINICAL CARE Speaker: Dr. Lisa Barbera, Radiation Oncologist, Odette Cancer Centre, Senior Scientist, Sunnybrook Research Institute, Adjunct Scientist, Institute for Clinical Evaluative Studies, Provincial Lead, Patient Reported Outcomes, Cancer Care Ontario Objectives (25 minute presentation, followed by 10 minute Q&A) 1. Understand the evidence supporting the use of patient reported outcomes in routine clinical care. 2. Understand how PROS are being implemented in cancer care in Ontario. 3. Describe examples of how population level PRO data can be used in research. 16h20 17h00 ABSTRACTS POSTER PRESENTATION LIGHTNING ROUND Objectives 1. Describe recent research findings in the field of Medical Oncology. 2. Describe interesting cases in the field of Medical Oncology. HEALTH RELATED QUALITY OF LIFE IN ELDERLY OR FRAIL PATIENTS WITH ADVANCED COLORECTAL CANCER TREATED WITH DOSE REDUCED CAPECITABINE Dr. Daniel Breadner NEOADJUVANT CHEMOTHERAPY (NC) PRIOR TO TRIMODALITY THERAPY (TMT) FOR MUSCLE- INVASIVE BLADDER CANCER (MIBC) PATIENTS UNDERGOING A BLADDER SPARING APPROACH Dr. Di (Maria) Jiang CARDIAC MONITORING IN HER2 POSITIVE BREAST CANCER: LIFE SAVING PREVENTION OR HINDRANCE TO CANCER CARE? Dr. Moira Rushton-Marovac ADJUVANT THERAPY USE AND OUTCOMES OF STAGE II AND III COLORECTAL CANCER (CRC): COMPARISON OF YOUNG AND ELDERLY PATIENTS IN A LARGE, CONTEMPORARY, POPULATION-BASED CANADIAN DATABASE Dr. Haider Samawi THE CLINICAL UTILITY OF BASELINE CARDIAC ASSESSMENTS PRIOR TO ADJUVANT ANTHRACYCLINE CHEMOTHERAPY IN BREAST CANCER: A SYSTEMATIC REVIEW AND META- ANALYSISMINI Dr. Pierre O Brien INFLUENCE OF AGGRESSIVE-VARIANT PROSTATE CANCER (AVPC) FEATURES ON OUTCOME OF METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC) TREATED BY CHEMOHORMONAL THERAPY (CHT) Dr. Kim Koczka Thursday, April 26 / jeudi le 26 avril 2018 Ontario Heritage Trust CAMO Awards Dinner* CAMO members and one guest / Les membres de l ACOM et un invité 18h30 19h00 Welcome reception/ Réception de bienvenue 19h00 22h00 CAMO Awards Dinner BREAST CANCER: CHANGES IN DIAGNOSIS AND THERAPY OVER FIFTY YEARS Speaker: Dr. Kathleen Pritchard, MD FRCPC, Sunnybrook Odette Cencer Centre Objectives (45 minute presentation, followed by 10 minute Q&A) 1. Summarize the early history of breast cancer surgery 2. Summarize the early history of endocrine therapy for breast cancer 3. Summarize the early history of targeted therapy for breast cancer CAMO Pioneer Lecture Series Award Presentation / CAMO Best Resident Abstract Award Presentation

5 ******************** The Canadian Association of Medical Oncologists gratefully acknowledges the continued support of our scientific program by educational grants from: DIAMOND LEVEL PLATINUM LEVEL GOLD LEVEL SILVER LEVEL BRONZE LEVEL

6 NOTES